@Babbanap That is a good point but my concern is the risk the TGA won't see that point of view.
Hopefully PAR has provided strong evidence as to the urgency of the need for our game-changing drug.
Also the time frame for the best possible outcome with the TGA is still too far off for our current funding concerns.
research reports and media, page-4389
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.015(6.25%) |
Mkt cap ! $91.06M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 24.5¢ | $43.30K | 171.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9990 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 2572 | 1 |
View Market Depth
| Last trade - 15.58pm 16/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |